RNAZ - Why Transcode Therapeutics (RNAZ) Stock Is Down Nearly 70% | Benzinga
Transcode Therapeutics Inc (NASDAQ: RNAZ) shares are trading lower by 69% to $0.79 Tuesday morning after the company priced its $8 million public offering of 15.7 million shares at $0.51 per share.
Transcode Therapeutics says the closing of ...
RNAZ) Stock Is Down Nearly 70%>Full story available on Benzinga.com